Learn why cord blood may be an excellent starting material for your therapy

Cord blood has been used to provide life-saving treatments to patients for decades, but its full potential has not yet been tapped. Learn about scalability considerations when using cord blood.

During this hour long on-demand webinar, our panelists discuss:

  • Why it’s essential to have a good understanding of critical starting material attributes and how this may impact your cord blood starting material supply
  • How and why cord blood is a valuable starting material for emerging cell therapies
  • How sourcing cord blood units from multiple banks is critical to achieve supply scalability and sustainability
  • Why alignment on necessary banking practice updates will ensure scalable supply and facilitate future cord blood use



Joy Aho, PhD
Director, Product Management
NMDP BioTherapies

Wouter van’t Hof, PhD
Director, Cord Blood Bank & CEO, Cleveland Cell Therapy Incubator
Cleveland Cord Blood Center

Ann Kaestner
CCBB Associate Director
Carolinas Cord Blood Bank


View Webinar